Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$120K Buy
23,464
+1,464
+7% +$8.94K ﹤0.01% 1702
2026
Q1
$132K Buy
22,000
+3,053
+16% +$20.2K ﹤0.01% 1535
2025
Q4
$110K Buy
18,947
+468
+3% +$2.61K ﹤0.01% 1461
2025
Q3
$102K Buy
18,479
+203
+1% +$1.1K ﹤0.01% 1438
2025
Q2
$71.6K Buy
18,276
+686
+4% +$2.83K ﹤0.01% 1437
2025
Q1
$86.4K Buy
17,590
+527
+3% +$2.83K ﹤0.01% 1363
2024
Q4
$86.5K Buy
17,063
+1,262
+8% +$6.97K ﹤0.01% 1381
2024
Q3
$109K Buy
15,801
+192
+1% +$1.13K ﹤0.01% 1311
2024
Q2
$116K Buy
15,609
+824
+6% +$5.79K ﹤0.01% 1229
2024
Q1
$108K Buy
14,785
+673
+5% +$5.76K ﹤0.01% 1236
2023
Q4
$87.5K Buy
14,112
+1,575
+13% +$7.07K ﹤0.01% 1212
2023
Q3
$51.2K Hold
12,537
﹤0.01% 1200
2023
Q2
$42.5K Buy
+12,537
New +$51.4K ﹤0.01% 1236

Other funds holding ARDX

Xponance's ARDX Position: Q2 2026 in Review

Xponance increased its Ardelyx (ARDX) stake by 6.7% in Q2 2026, buying an estimated $8.94K and bringing the position to 23,464 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #1702.

Xponance first reported a position in ARDX in Q2 2023 and has held it in 13 quarters since. The position peaked at $132K in Q1 2026. 249 funds tracked by Wall St. Rank hold ARDX as of Q2 2026.

  • Xponance held 23,464 shares of Ardelyx worth $120K as of Q2 2026.
  • Xponance bought 1,464 Ardelyx shares in Q2 2026, an estimated $8.94K.
  • Ardelyx made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1702 holding.
  • Xponance first reported a position in Ardelyx in Q2 2023 and has held it in 13 quarters since.
  • Xponance's Ardelyx position peaked at $132K in Q1 2026.
  • 249 funds tracked by Wall St. Rank held Ardelyx as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.